318 related articles for article (PubMed ID: 33879237)
1. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates.
Bostanghadiri N; Ardebili A; Ghalavand Z; Teymouri S; Mirzarazi M; Goudarzi M; Ghasemi E; Hashemi A
BMC Res Notes; 2021 Apr; 14(1):151. PubMed ID: 33879237
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
3. Distribution of smf-1, rmlA, spgM and rpfF genes among Stenotrophomonas maltophilia isolates in relation to biofilm-forming capacity.
Azimi A; Aslanimehr M; Yaseri M; Shadkam M; Douraghi M
J Glob Antimicrob Resist; 2020 Dec; 23():321-326. PubMed ID: 33137534
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between the Biofilm Genes and Antibiotic Resistance in
Sameni F; Hajikhani B; Hashemi A; Owlia P; Niakan M; Dadashi M
Int J Microbiol; 2023; 2023():8873948. PubMed ID: 37692920
[TBL] [Abstract][Full Text] [Related]
6. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S; Gutiérrez-Ferman JL; Morfín-Otero R; Rodríguez-Noriega E; Estrada-Rivadeneyra D; Rivas-Morales C; Llaca-Díaz JM; Camacho-Ortíz A; Mendoza-Olazarán S; Garza-González E
J Med Microbiol; 2014 Nov; 63(Pt 11):1524-1530. PubMed ID: 25165124
[TBL] [Abstract][Full Text] [Related]
7. Analysis of biofilm formation in nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria: An 11-year study (2011-2022).
Strateva T; Trifonova A; Sirakov I; Borisova D; Stancheva M; Keuleyan E; Setchanova L; Peykov S
Acta Microbiol Immunol Hung; 2023 Mar; 70(1):11-21. PubMed ID: 36640262
[TBL] [Abstract][Full Text] [Related]
8. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia.
Zhuo C; Zhao QY; Xiao SN
PLoS One; 2014; 9(10):e108409. PubMed ID: 25285537
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Molecular Epidemiology of
Duan Z; Qin J; Li C; Ying C
Front Cell Infect Microbiol; 2020; 10():411. PubMed ID: 32850503
[No Abstract] [Full Text] [Related]
10. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
11. Detection of multidrug resistant environmental isolates of
Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
[No Abstract] [Full Text] [Related]
12. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
13. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
14. Stenotrophomonas maltophilia: Genotypic Characterization of Virulence Genes and The Effect of Ascorbic Acid on Biofilm Formation.
ElBaradei A; Yakout MA
Curr Microbiol; 2022 May; 79(6):180. PubMed ID: 35508743
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.
Sun E; Liang G; Wang L; Wei W; Lei M; Song S; Han R; Wang Y; Qi W
Braz J Infect Dis; 2016; 20(4):365-73. PubMed ID: 27183359
[TBL] [Abstract][Full Text] [Related]
16. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
17.
Alcaraz E; Garcia C; Papalia M; Vay C; Friedman L; Passerini de Rossi B
J Med Microbiol; 2018 Jul; 67(7):992-1002. PubMed ID: 29799387
[No Abstract] [Full Text] [Related]
18. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Lee YL; Liu CE; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
[TBL] [Abstract][Full Text] [Related]
19. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
20.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
